Meeting News
Advertisement
RNA sequencing showed decreased gene expression levels of the NF-κB target genes IL1β and IER3 after emavusertib treatment.
The meeting had more than 2,500 registrants attending in person or online.
Researchers conducted interviews to gather the perspectives of both clinicians and nurses.
Nitin Jain, MD, joins Chadi Nabhan, MD, MBA, FACP, Host of The HemOnc Pulse, to discuss unmet needs in CLL.
Researchers conducted a cross-sectional survey of patients with multiple myeloma to address the question.
The award was created in honor of Michael J. Keating, MD, a founding member and past president of SOHO.
Advertisement
Dr. Richter discusses the data he presented during the 20th IMS Annual Meeting Exposition.
Researchers evaluated 1,704 patients with triple-class exposure, including 1,072 who had four-plus previous lines of therapy.
Dr. Nastoupil spoke about how the meeting can help clinicians learn how apply knowledge from the latest research.
Karun Neupane, MD, discusses why the meeting was a valuable experience for him as a first-time attendee.
Researchers presented updated data from the phase I XPORT-MF-034 trial at the Eleventh SOHO Annual Meeting.
Dr. de Lima discusses progress and remaining challenges with allogeneic CAR-T and other cellular therapy products.
The proof-of-concept study showed that noninvasive hemoglobin measurement is “feasible,” but there were several ...
One aim is to evaluate the efficacy of oral decitabine/cedazuridine and magrolimab in intermediate to HR MDS.
Swaminathan Iyer, MD, joins Chadi Nabhan, MD, MBA, FACP, to discuss advances in T-cell lymphoma.
Alessandra Ferrajoli, MD, discusses her presentation on the topic during the Eleventh Annual Meeting of SOHO.
Joseph Khoury, MD; Sanam Loghavi, MD; and Chadi Nabhan, MD, MBA, FACP, discuss the MDS classification systems.
Dr. Anderson spoke about her plenary session on the topic at the Eleventh Annual Meeting of SOHO.
Dr. Garcia-Manero discusses key data from the phase III COMMANDS trial.
All patients included in the study required treatment and had not previously received psychiatric treatment.
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Elias Jabbour, MDAssociate Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center
Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.